Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Sign up for Axios NW Arkansas
Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters
Both sides of the Atlantic are delivering the same message right now: COVID-19 vaccine boosters will become a regular part of our life for years to come.
Why it matters: The variants are spreading fast, but our technology can keep pace on developing boosters, experts say.
- From the U.K.: “We have to appreciate that we were always going to have to have booster doses; immunity to coronavirus doesn’t last forever,” COVID-19 Genomics UK head Sharon Peacock told Reuters.
- From the U.S.: Pfizer CEO Albert Bourla told "Axios on HBO" the company expects people to need annual boosters for many years. Pfizer can turn around new versions of its vaccine in 116 days, if necessary.
The big picture: Peacock told Reuters she's most concerned about the COVID variant from South Africa and is also paying attention to the ones from the U.K. and Brazil.
- “One of the things that the virus has taught me is that I can be wrong quite regularly — I have to be quite humble in the face of a virus that we know very little about still."
What's next: France, Germany, Italy and Spain are suspending use of the AstraZeneca vaccine as EU regulators investigate reports of blood clots in recipients.